Anatomical extent of pelvic lymphadenectomy in bladder and prostate cancer

European Urology, Supplements

Volumn 4, Issue 4 SPEC. ISS., 2005, Pages 15-24

  Heidenreich, Axel ^a   Ohlmann, Carsten H ^a   Polyakov, Sergej ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA BIFURCATION; BLADDER CANCER; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CYSTECTOMY; FROZEN SECTION; HUMAN; ILIAC BONE; LYMPHOID TISSUE; MORBIDITY; NOMOGRAM; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

EID: 13544265304     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2005.01.006     Document Type: Conference Paper

References (42)

1. E.D. Crawford, J.T. Batuello, P. Snow, E.J. Gamito, D.G. McLeod, and A.W. Partin The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma Cancer 88 2000 2105 2109
2. J.T. Batuello, E.J. Gamito, E.D. Crawford, M. Han, A.W. Partin, and D.G. McLeod Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer Urology 57 2001 481 485
3. A.W. Partin, M.W. Kattan, Subing ENP, P.C. Walsh, K.J. Wojno, and J.E. Oesterling Combination of prostate-specific antigen, clinical stage, and Gleason sum to predict pathological stage of localized prostate cancer: a multi-institutional update JAMA 277 1997 1445 1451
4. P. Bader, F.C. Burkhard, R. Markwalder, and U.E. Studer Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a hance of cure? J Urol 169 2003 849 854
5. A. Heidenreich, R. von Knobloch, and Z. Varga Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy in prostate cancer: high incidence of lymph node metastases J Urol 167 2001 1681 1684
6. Heidenreich A, von Knobloch R, Varga Z, Hofmann R. Extended pelvic lymphadenectomy in men undergoing radical retropubic prostatectomy-data on >300 cases. J Clin Oncol 2004;22(14S) [Proc ASCO, Abstract 4612].
7. M. Algari, M.D. Colton, E.J. Seidmon, R.E. Greenberg, and P.M. Hanno The staging pelvic lymphadenectomy: implication as an adjunctive procedure for clinically localized prostate cancer J Urol 162 1997 243 246
8. K. Weingärtner, A. Ramaswamy, A. Bittinger, E.W. Gerharz, D. Vöge, and H. Riedmiller Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic J Urol 156 1996 1969 1971
9. J.M. Gil-Vernet Prostate cancer: anatomical and surgical considerations Br J Urol 78 1996 161 168
10. P. Narayan, G. Fournier, V. Gajendran, R. Leidich, R. Lo, and J.S. Wolf Utility of preoperative serum prostate specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer Urology 44 1994 519 524
11. D.L. Bluestein, D.G. Bostwick, E.J. Bergstralh, and J.E. Oesterling Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer J Urol 151 1994 1315 1320
12. S. Conrad, M. Graefen, U. Pichlmaier, R.P. Henke, P.G. Hammerer, and H. Huland Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastasis in patients with clinically localized prostate cancer J Urol 159 1998 2023
13. S. Conrad, M. Graefen, U. Pichlmaer, R.P. Henke, A. Ebersdobler, and P.G. Hammerer Prospective validation of an algorithm with systematic sextant biopsy to predict lymph node metastasis in patients with clinically localized prostate cancer J Urol 167 2002 521
14. A. Haese, J.I. Epstein, H. Huland, and A.W. Partin Validation of a biopsy based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostatic carcinoma Cancer 95 2002 1016
15. Y. Naya, and R.J. Babaian The predictors of pelvic lymph node metastasis at radical retropubic prostatectomy J Urol 170 2003 2306 2310
16. M. Schuhmacher, F. Burkhardt, R. Markwalder, and U. Studer Lymph nodes metastases in patients with prostate cancer and with a PSA <10 ng/ml Eur Urol Suppl 3 2 2004 17 [Abstract 57]
17. D. Weckermann, F. Wawroschek, and R. Harzmann Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy? Eur Urol 47 2005 45 51
18. J.F. Dillioglugil, B.D. Leibman, N.S. Leibman, M.W. Kattan, A.L. Rosas, and P.T. Scardino Risk factors for complications and morbidity after radical retropubic prostatectomy J Urol 157 1997 1760 1767
19. A. Fergany, P.A. Kupelian, H.S. Levin, C.D. Zippe, C. Reddy, and E.A. Klein No difference in biochemical failure reates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients Urology 56 2000 92 95
20. M.V. Meng, and P.R. Carroll When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis J Urol 164 2000 1235 1240
21. El-Galley RES, T.E. Keane, J.A. Petros, W.H. Sanders, H.S. Clarke, and G.A. Cotsonis Evaluation of staging lymphadenectomy in prostate cancer Urology 52 1998 663 667
22. L. Cheng, H. Zincke, M.L. Blute, E.J. Bergstralh, B. Scherer, and D.G. Bostwick Risk of prostate cancer death in patients with lymph node metastasis Cancer 91 2001 66 71
23. Messing EM, Manola J, Sarosdy M, et al. Immediate hormonal therapy versus observation after radical prostatectomy and pelvic lymphadenectomy for node positive prostate cancer: at 10 years results of EST3886. J Clin Oncol 2004;22(14S) [Proc ASCO, Abstract 4570].
24. F. Wawroschek, H. Vogt, D. Weckermann, Wagner Th, and R. Harzmann Radioisotope guided pelvic lymph node dissection for prostate cancer J Urol 166 2001 1715 1719
25. T.J. Polasczik, M.J. Manyak, M.K. Haseman, R.T. Gurganus, B. Rogers, and R.T. Maguire Comparison of clinical staging algorithms and 111Indium-Capromab Pendetide Immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients Cancer 85 1999 1586 1592
26. D.B. Sodee, N. Malguria, P. Faulhaber, M.I. Resnick, and J. Albert Bakale G, and the Prostacint Imaging Centers. Multicenter Prostacint imaging findings in 2154 patients with prostate cancer Urology 56 2000 988 993
27. H.B. Grossmann, R.B. Natale, and C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
28. H.W. Herr, J.R. Faulkner, and H.B. Grossman Surgical factors influence bladder cancer outcomes: a cooperative group report J Clin Oncol 22 2004 2781 2789
29. H. Herr, C. Lee, S. Chang, S. Lerner for the Bladder Cancer Collaborative Group Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report J Urol 171 2004 1823 1828
30. R.D. Mills, W.H. Turner, A. Fleischmann, R. Markwalder, G.N. Thalmann, and U.E. Studer Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy J Urol 166 2001 19 23
31. W.H. Herr, B.H. Bochner, and G. Dalbagni Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer J Urol 167 2003 1295 1297
32. J. Leissner, R. Hohenfellner, J.W. Thüroff, and H.K. Wolf Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis BJU Int 85 2000 817 821
33. J.P. Stein, J. Cai, S. Groshen, and D.G. Skinner Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en-bloc pelvic lymphadenectomy: the concept of lymph node density J Urol 170 2003 35
34. M. Abdel-Latif, H. Abol-Eneim, M. El-Baz, and M.A. Ghoneim Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis J Urol 172 2004 85 89
35. W.H. Herr Superiority of ratio based lymph node staging for bladder cancer J Urol 169 2003 943
36. B.H. Bochner, H.W. Herr, and V.E. Reuter Impact of separate versus en bloc lymph node dissection in the number of lymph nodes retrieved in cystectomy specimens J Urol 166 2001 2295
37. J. Leissner, E.P. Allhoff, R. Hohenfellner, and H.K. Wolf Ranking of pelvic lymphadenectomy in therapy and prognosis of carcinoma of the bladder Akt Urol 34 2003 392 397
38. A.L. Poulsen, T. Horn, and K. Steven Radical cystectomy: extending limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall J Urol 160 1998 2015 2019
39. J. Leissner, M.A. Ghoneim, and H. Abol-Eneim Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study J Urol 171 2004 139 144
40. B.H. Bochner, D. Cho, and H.W. Herr Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping J Urol 172 2004 1286 1290
41. H. Abol-Enein, M. El-Baz, M.A. Abd El-Hameed, M. Abdel-Latif, and M.A. Ghoneim Lymph node involvement in patients with bladder cancer treated by radical cystectomy: a patho-anatomical study - a single center experience J Urol 172 2004 1818 1821
42. B.H. Bochner, H.W. Herr, and V.E. Reuter Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens J Urol 166 2001 2295 2296